Baxter Bros Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $574K | Hold |
9,965
| – | – | 0.07% | 116 |
|
|
2026
Q1 | $604K | Sell |
9,965
-166
| -2% | -$9.68K | 0.07% | 111 |
|
|
2025
Q4 | $546K | Sell |
10,131
-270
| -3% | -$13K | 0.06% | 112 |
|
|
2025
Q3 | $469K | Sell |
10,401
-1,505
| -13% | -$70.3K | 0.05% | 116 |
|
|
2025
Q2 | $551K | Sell |
11,906
-334
| -3% | -$16.4K | 0.07% | 107 |
|
|
2025
Q1 | $747K | Sell |
12,240
-1,008
| -8% | -$58.8K | 0.1% | 93 |
|
|
2024
Q4 | $749K | Sell |
13,248
-702
| -5% | -$39.2K | 0.1% | 91 |
|
|
2024
Q3 | $722K | Sell |
13,950
-2,254
| -14% | -$106K | 0.09% | 93 |
|
|
2024
Q2 | $673K | Sell |
16,204
-1,254
| -7% | -$56.1K | 0.09% | 92 |
|
|
2024
Q1 | $947K | Sell |
17,458
-4,498
| -20% | -$229K | 0.12% | 81 |
|
|
2023
Q4 | $1.13M | Sell |
21,956
-8,919
| -29% | -$468K | 0.16% | 80 |
|
|
2023
Q3 | $1.79M | Sell |
30,875
-7,403
| -19% | -$454K | 0.27% | 66 |
|
|
2023
Q2 | $2.45M | Sell |
38,278
-273
| -0.7% | -$18.3K | 0.36% | 58 |
|
|
2023
Q1 | $2.67M | Sell |
38,551
-793
| -2% | -$55.9K | 0.42% | 54 |
|
|
2022
Q4 | $2.83M | Sell |
39,344
-1,795
| -4% | -$135K | 0.47% | 52 |
|
|
2022
Q3 | $2.92M | Sell |
41,139
-69
| -0.2% | -$5K | 0.52% | 50 |
|
|
2022
Q2 | $3.17M | Sell |
41,208
-1,444
| -3% | -$110K | 0.57% | 47 |
|
|
2022
Q1 | $3.12M | Sell |
42,652
-1,714
| -4% | -$115K | 0.47% | 49 |
|
|
2021
Q4 | $2.77M | Sell |
44,366
-5,373
| -11% | -$315K | 0.4% | 52 |
|
|
2021
Q3 | $2.94M | Sell |
49,739
-1,241
| -2% | -$81.7K | 0.47% | 49 |
|
|
2021
Q2 | $3.41M | Sell |
50,980
-1,290
| -2% | -$84.1K | 0.54% | 46 |
|
|
2021
Q1 | $3.3M | Buy |
52,270
+4,010
| +8% | +$249K | 0.57% | 46 |
|
|
2020
Q4 | $2.99M | Buy |
48,260
+2,923
| +6% | +$180K | 0.57% | 42 |
|
|
2020
Q3 | $2.73M | Buy |
45,337
+3,108
| +7% | +$187K | 0.59% | 42 |
|
|
2020
Q2 | $2.48M | Buy |
42,229
+8,430
| +25% | +$504K | 0.58% | 44 |
|
|
2020
Q1 | $1.88M | Buy |
33,799
+14,841
| +78% | +$907K | 0.49% | 47 |
|
|
2019
Q4 | $1.22M | Buy |
18,958
+1,446
| +8% | +$82.8K | 0.25% | 61 |
|
|
2019
Q3 | $888K | Sell |
17,512
-2,195
| -11% | -$103K | 0.2% | 68 |
|
|
2019
Q2 | $894K | Buy |
19,707
+2,751
| +16% | +$128K | 0.2% | 65 |
|
|
2019
Q1 | $809K | Sell |
16,956
-1,066
| -6% | -$53.1K | 0.19% | 71 |
|
|
2018
Q4 | $937K | Sell |
18,022
-1,296
| -7% | -$69.6K | 0.25% | 62 |
|
|
2018
Q3 | $1.2M | Buy |
19,318
+1,404
| +8% | +$83.3K | 0.29% | 59 |
|
|
2018
Q2 | $991K | Buy |
17,914
+249
| +1% | +$13.4K | 0.27% | 60 |
|
|
2018
Q1 | $1.12M | Sell |
17,665
-1,100
| -6% | -$70.8K | 0.3% | 57 |
|
|
2017
Q4 | $1.15M | Buy |
18,765
+2,731
| +17% | +$171K | 0.32% | 60 |
|
|
2017
Q3 | $1.02M | Sell |
16,034
-796
| -5% | -$46.5K | 0.29% | 61 |
|
|
2017
Q2 | $938K | Sell |
16,830
-1,997
| -11% | -$109K | 0.28% | 63 |
|
|
2017
Q1 | $1.02M | Buy |
18,827
+29
| +0.2% | +$1.59K | 0.32% | 56 |
|
|
2016
Q4 | $1.1M | Sell |
18,798
-221
| -1% | -$12.1K | 0.35% | 54 |
|
|
2016
Q3 | $1.03M | Buy |
19,019
+6,853
| +56% | +$440K | 0.35% | 58 |
|
|
2016
Q2 | $895K | Buy |
+12,166
| New | +$860K | 0.31% | 57 |
|
|
2015
Q4 | $855K | Buy |
12,430
+2,206
| +22% | +$146K | 0.32% | 61 |
|
|
2015
Q3 | $680K | Hold |
10,224
| – | – | 0.25% | 72 |
|
|
2015
Q2 | $680K | Buy |
10,224
+1,425
| +16% | +$93.9K | 0.25% | 72 |
|
|
2015
Q1 | $568K | Buy |
8,799
+500
| +6% | +$31.3K | 0.21% | 74 |
|
|
2014
Q4 | $490K | Sell |
8,299
-134
| -2% | -$7.56K | 0.18% | 75 |
|
|
2014
Q3 | $432K | Buy |
8,433
+2
| +0% | +$100 | 0.17% | 77 |
|
|
2014
Q2 | $409K | Hold |
8,431
| – | – | 0.17% | 78 |
|
|
2014
Q1 | $438K | Hold |
8,431
| – | – | 0.2% | 68 |
|
|
2013
Q4 | $448K | Sell |
8,431
-1,800
| -18% | -$91.7K | 0.21% | 67 |
|
|
2013
Q3 | $473K | Buy |
10,231
+2,100
| +26% | +$92.2K | 0.26% | 60 |
|
|
2013
Q2 | $363K | Buy |
+8,131
| New | +$353K | 0.22% | 61 |
|
Other funds holding BMY
Baxter Bros Inc's BMY Position: Q2 2026 in Review
Baxter Bros Inc held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 9,965 shares worth $574K. The position accounts for 0.07% of the portfolio, ranked #116.
Baxter Bros Inc first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.41M in Q2 2021. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Baxter Bros Inc held 9,965 shares of Bristol-Myers Squibb worth $574K as of Q2 2026.
- Baxter Bros Inc left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.07% of Baxter Bros Inc's portfolio in Q2 2026, its #116 holding.
- Baxter Bros Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Baxter Bros Inc's Bristol-Myers Squibb position peaked at $3.41M in Q2 2021.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.